0001209191-19-045647.txt : 20190812 0001209191-19-045647.hdr.sgml : 20190812 20190812194703 ACCESSION NUMBER: 0001209191-19-045647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190809 FILED AS OF DATE: 20190812 DATE AS OF CHANGE: 20190812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fowler John Franklin CENTRAL INDEX KEY: 0001744263 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 191017988 MAIL ADDRESS: STREET 1: C/O KEZAR LIFE SCIENCES, INC. STREET 2: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-09 0 0001645666 Kezar Life Sciences, Inc. KZR 0001744263 Fowler John Franklin C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 CEO Common Stock 2019-08-09 4 P 0 500 5.255 A 293204 D Common Stock 2019-08-09 4 P 0 750 5.0147 A 293954 I By Trust The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.9642 to $5.1143 on August 9, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of issuer, full information regarding the number of shares purchased at each separate price. /s/ Marc Belsky, Attorney-in-Fact 2019-08-12